Search Results - "Sokolova, Tatyana N"

Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer by Moiseyenko, Fedor V., Kuligina, Ekaterina S., Zhabina, Albina S., Belukhin, Sergey A., Laidus, Tatiana A., Martianov, Aleksandr S., Zagorodnev, Kirill A., Sokolova, Tatyana N., Chuinyshena, Svetlana A., Kholmatov, Maxim M., Artemieva, Elizaveta V., Stepanova, Ekaterina O., Shuginova, Tatiana N., Volkov, Nikita M., Yanus, Grigoriy A., Imyanitov, Evgeny N.

“…Purpose This study aimed to analyze changes in the plasma concentration of EGFR-mutated circulating tumor DNA (ctDNA) occurring immediately after the start of…”
Get full text

Unexpected "Lazarus response" to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer by Emshanov, Alexey V, Nesterov, Denis V, Sokolova, Tatyana N, Amankwah, Priscilla S, Imyanitov, Evgeny N

“…Early clinical trials aimed to halt cancer progression by inhibiting the growth of new blood vessels in tumors through single-agent targeted therapy with…”
Get full text

HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles by Kuligina, Ekaterina S, Romanko, Alexandr A, Jankevic, Tatjana, Martianov, Aleksandr S, Ivantsov, Alexandr O, Sokolova, Tatyana N, Trofimov, Dmitry, Kashyap, Aniruddh, Cybulski, Cezary, Lubiński, Jan, Imyanitov, Evgeny N

“…Female carriers of germline BRCA1 mutations almost invariably develop breast cancer (BC); however, the age at onset is a subject of variation. We hypothesized…”
Get full text

Content of circulating tumor DNA depends on the tumor type and the dynamics of tumor size, but is not influenced significantly by physical exercise, time of the day or recent meal by Kuligina, Ekaterina S., Meerovich, Roman, Zagorodnev, Kirill A., Kholmatov, Maxim M., Sokolova, Tatyana N., Laidus, Tatiana A., Romanko, Aleksandr A., Martianov, Aleksandr S., Anisimova, Maria O., Zaitseva, Olga A., Yatsuk, Olga S., Yanus, Grigoriy A., Imyanitov, Evgeny N.

“…•The amount of ctDNA is higher in patients with tumor progression vs. subjects with the control of malignant disease.•Time of the day, recent meal or moderate…”
Get full text

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients by Moiseyenko, Vladimir M., Moiseyenko, Fedor V., Yanus, Grigoriy A., Kuligina, Ekatherina Sh, Sokolenko, Anna P., Bizin, Ilya V., Kudriavtsev, Alexey A., Aleksakhina, Svetlana N., Volkov, Nikita M., Chubenko, Vyacheslav A., Kozyreva, Kseniya S., Kramchaninov, Mikhail M., Zhuravlev, Alexandr S., Shelekhova, Kseniya V., Pashkov, Denis V., Ivantsov, Alexandr O., Venina, Aigul R., Sokolova, Tatyana N., Preobrazhenskaya, Elena V., Mitiushkina, Natalia V., Togo, Alexandr V., Iyevleva, Aglaya G., Imyanitov, Evgeny N.

“…Background Colorectal carcinomas (CRCs) are sensitive to treatment by anti-epidermal growth factor receptor (EGFR) antibodies only if they do not carry…”
Get full text

Abstract 799: Reduced diversity of HLA class II alleles may contribute to the early manifestation of breast cancer in BRCA1 mutation carriers by ShKuligina, Ekaterina, Romanko, Alexandr A., Jankevic, Tatjana, Martianov, Aleksandr S., Sokolova, Tatyana N., Ivantsov, Alexandr O., Imyanitov, Evgeny N.

“…Abstract Female carriers of germline BRCA1 mutation almost inevitably develop breast cancer (BC). However, the age of BRCA1-associated cancer onset varies…”
Get full text

Abstract 717: Presence of distant metastases and disease progression but not tumor size, lymph node involvement, circadian rhythms, prior physical exercise or recent food consumption influence the concentration of circulating tumor DNA in cancer patients by Kuligina, Ekaterina Sh, Meerovich, Roman, Zagorodnev, Kirill A., Kholmatov, Maxim M., Laidus, Tatiana A., Martianov, Aleksandr S., Sokolova, Tatyana N., Anisimova, Maria O., Yanus, Grigoriy A., Imyanitov, Evgeny N.

“…Abstract Liquid biopsy is potentially useful for early tumor detection, monitoring of cancer disease during treatment and diagnosis of therapy-related…”
Get full text

Unexpected "Lazarus response" to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer by Emshanov, Alexey V, Nesterov, Denis V, Sokolova, Tatyana N, Amankwah, Priscilla S, Imyanitov, Evgeny N

“…Early clinical trials aimed to halt cancer progression by inhibiting the growth of new blood vessels in tumors through single-agent targeted therapy with…”
Get full text

The phase-space volume effect on the electron beam forming in the EOS of Ka-band devices with a high aspect ratio field-emission cathode by Paramonov, Yury N., Morev, Sergey P., Muraviev, Eduard K., Darmaev, Alexander N., Komarov, Dmitry A., Shesterkin, Vasily I., Sokolova, Tatyana N., Bessonov, Dmitry A.

“…The research results of the feasibility of using field-emission cathode cells with glassy carbon emitters with large aspect ratio in microwave K a -band…”
Get full text